Global View Investment Blog

Rearview Mirror Investing: Why Morningstar Stars Can Mislead Investors

At Global View Investment Advisors, we believe that successful investing requires a clear view of our current location and the implications for the path forward. While Morningstar stars provide a useful starting point for screening, they shouldn't be the ending point. Unfortunately, many investors navigate their portfolios by looking exclusively in the rearview mirror, guided by the ubiquitous Morningstar Star Rating.

Morningstar Star Ratings are one of the most widely recognized fund rating systems in the investment industry. Funds receive between one and five stars based on their historical risk-adjusted performance relative to similar funds in the same category, with higher ratings reflecting stronger risk-adjusted returns compared to peers over past time periods.

While a 5-star rating is often used as a seal of approval in marketing materials, it is important to remember that these stars are a purely quantitative, backward-looking measure. They tell you how funds performed in the past, but they offer zero insight into how it will perform tomorrow. It is quite possible that a high star rating may point to poorer returns ahead!


The Concern About the "Star" Methodology: Morningstar Star Ratings Explained

The Morningstar system ranks funds on a strict bell curve within specific categories, based upon past performance. Only the top 10% receive 5 stars, while the bottom 10% receive 1 star. This creates several mechanical problems for the average investor:

  • Mathematical lag: Ratings are weighted averages of 3-, 5-, and 10-year trailing returns. This creates a cushion where a fund can maintain a high rating long after its current performance has soured, simply because a few spectacular years from the past are still propping up the math.
  • Style drift penalties: If a manager is successful and their small-cap holdings grow into mid-cap stocks, Morningstar may reclassify the fund. Once moved, that fund is compared to a totally new peer group, often resulting in an automatic downgrade that has nothing to do with the manager's actual skill and ignores the track record of success in its previous category.
  • Misclassification: Research indicates some managers deliberately alter holdings to force a reclassification into easier categories where their mediocre returns look like 5-star performance compared to a weaker peer group. Additionally, some funds hold large portions of their investments in companies that are outside of their labeled category. One example is an Emerging Market Fund that owns 40% to 45% US stocks (real example, and the fund performance looks great compared to pure emerging market funds due to the recent US outperformance).
  • Past performance limitations: The Star Rating system is based solely on recent performance, using trailing 3-, 5-, and 10-year returns. Recent performance is often misleading, unless investors have complete knowledge of what created the performance. Also, performance will often have a natural ebb and flow over long periods of time. It may be a mistake to buy a strategy that has performed well recently, because the recent excess performance may produce future underperformance as assets mean-revert.


A Tale of Two Strategies: BCSVX vs. TOVYX

(Global View is NOT an investor in either fund—we are simply using the funds to illustrate our message. Global View is not affiliated with either fund, and Global View receives no compensation from them.)

To see these flaws in action, we can look at two funds currently sitting in the Foreign Small/Mid Growth category. On paper, they are peers; however, this comparison could not be further from the truth.

The Fall of the 5-Star Favorite: BCSVX

In 2018, the Brown Capital Management International Small Company Fund (BCSVX) held a 5-star Morningstar rating, reflecting strong prior risk-adjusted performance relative to its peers at the time. However, in the following years, the fund experienced periods of significant volatility due to its heavy concentration in hyper-growth tech and healthcare.

  • The crash: When interest rates rose in 2022, the fund plummeted -31.56%.
  • The delay: Despite this, BCSVX didn't hit bottom immediately. Its stellar 2019–2020 returns propped it up at 3 stars for years.
  • The present: As of May 2026, those "good years" have cycled out. BCSVX now holds a 2-star rating, reflecting a 5-year return of 3.69%.

The Asset Mix Mismatch: TOVYX

A probable misleading comparison from the Star Rating system is BCSVX to the American Beacon IMC International Small Cap Fund (TOVYX). TOVYX is also classified within the same Morningstar category; however, its underlying portfolio structure is meaningfully different.

While both funds are grouped as Foreign Small/Mid Growth, TOVYX maintains:

  • Large-cap exposure: Over 22% of the portfolio is in large-cap stocks.
  • Mid-cap dominance: Over 62% of the portfolio is in mid-cap companies.
  • Weighted avg. market cap: At $7.07 billion, it is significantly larger than a true small-cap fund.

Metric

TOVYX

BCSVX

Primary Focus

Mid/large cap stability

Micro/small cap growth

Star Rating (May 2026)

5 stars

2 stars

 

When Morningstar puts BCSVX and TOVYX in the same bucket, it ignores the market cap mismatch and creates an apples-to-oranges comparison.

In a volatile market, TOVYX’s large-cap anchor helps it outperform, earning it more stars. Meanwhile, a fund like BCSVX—which stays true to its small/micro-cap mission—gets penalized with 2 stars simply because its specific asset class is out of favor. The star rating isn't telling you which manager is better; it's often just telling you which size of company has performed better lately.


The Global View Perspective

At Global View, we don't look at the stars; we look at the DNA of the fund and the professionals who operate it. We analyze style drift, market cap exposure, and concentration risk to ensure your portfolio is built for the next market cycle, not the last one.

Are you choosing funds because of their current backward-looking ratings or because of their future potential? Let’s look under the hood together. Schedule a complimentary Fund DNA Review with a Global View advisor to audit your portfolio's hidden risks.


Disclaimer: Past performance is no guarantee of future results. Information regarding BCSVX and TOVYX is based on data available as of May 2026. For personalized investment strategies, consult with a Global View advisor.

 

Adam Wiles

Written by Adam Wiles

Adam is a Partner at Global View. Adam’s primary focus is on investment strategy, retirement planning, risk management, and new client identification. He has extensive experience and training in identifying client’s needs and explaining the solutions that meet those needs. He worked with Merrill Lynch for 2 years prior to joining Global View. Prior to Merrill Lynch, Adam worked 10 years, in several trading capacities, within the Commodity Lumber business.